Our results point to a greater relevance of the ACE2/Ang (1-7)/MAS receptor axis than of the ACE/Ang-II/angiotensin type 1 receptor axis on COVID-19–associated CSS and vascular complications and to the therapeutic potential of Ang (1-7) in this disease. The gene discussed is ACE; the disease is COVID-19.